1 / 8

Head & Neck Cancer Drugs Market to show $2.2 Bn by 2025, Globally

The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is expected to reach $2,281 million by 2025, growing at a CAGR of 7.3% from 2018 to 2025.

sanketsolanki
Download Presentation

Head & Neck Cancer Drugs Market to show $2.2 Bn by 2025, Globally

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Head & Neck Cancer Drugs Market to Reach $2.2 Bn by 2025 Opportunity Analysis and IndustryForecast, 2016-2023 Global Opportunity Analysisand IndustryForecast, 2018-2025

  2. Recent launch of advance drugs for treatment of head and neck cancer,increase in global geriatric population and rise in consumption of tobacco & alcohol has fueled the growth of global head & neck cancer drugs market. Introduction • Growth opportunities in emerging market with rise in purchasing power, increase in incidence of head & neck cancer and developing healthcare infrastructure and rise in number of pipeline drugs have made space for multiple opportunities in the sector. • Chemotherapy contributed to nearly half of the total market and is expected to retain its headship status by 2025. • Increase in adoption of chemotherapeutics along with radiation therapy for treatment of head & neck cancer has coaled the growth of the market.

  3. Key Findings of theMarket • Based on sales channel, the online stores segment is expected to experience fastest market and is projected to grow at a CAGR of 10.2% during the forecast period 2018-2025. • Depending on drug class, the chemotherapy segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 4.0% from 2018 to 2025. • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.7% during the forecast period. Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/5174

  4. The study provides an in-depth analysis of the market along with the current head & neck cancer drugs market trends and future estimations to elucidate the imminent investment pockets. • It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities. • Head & neck cancer drugs market forecast is studied from 2018 to 2025. • A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities. • Head & neck cancer drugs market size and estimations are based on a comprehensive analysis of key developments in the head and neck cancer drugs industry. • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market. Key Benefits

  5. By Drug Class • Chemotherapy • Immunotherapy • Targeted Therapy • By Sales Channel • Hospital Pharmacies • Drug Stores & Retail Pharmacies • Online Stores MarketSegmentation • By Region • North America • Europe • Asia-Pacific • LAMEA

  6. AstraZeneca PLC, • Bristol-Myers Squibb Company, • Eli Lilly and Company (ARMO Biosciences), • Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.), • F. Hoffmann-La Roche Ltd. (Genentech, Inc.),  • Immutep Limited, • Merck & Co., Inc.,  • Others Key Players of theMarket For purchase enquiry, visit @https://www.alliedmarketresearch.com/checkout/156958

  7. About Allied MarketResearch: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective marketdomain. ContactUs: 5933 NE Win Sivers Drive, #205, Portland, OR 97220, UnitedStates. Int'l: +1-503-894-6022 TollFree: +1-800-792-5285 Fax: +1-800-792-5285 Contact Allied MarketResearch

  8. ThankYou! For MoreDetails Visit usat https://www.alliedmarketresearch.com/press-release/head-and-neck-cancer-drugs-market.html Follow UsOn:

More Related